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Introduction
Polybrominated diphenyl ethers (PBDEs) are 
flame retardants added to furniture,  carpet 
padding, electronic devices, and other con-
sumer products. Since their introduction 
in the 1970s, humans have accumulated 
PBDEs in their tissues via dust ingestion, 
dietary intake, absorption from dermal con-
tact, and inhalation [Centers for Disease 
Control and Prevention (CDC) 2009; 
Lorber 2008]. The body burden of PBDEs 
in Americans is about 10 times higher than 
in Europeans or Asians because of previ-
ous U.S. regulations (California Technical 
Bulletin 117) that required the addition of 
flame retardants to prevent burn injuries 
and property damage (SjÖdin et al. 2008; 
Stapleton et al. 2012). The PBDEs have 209 
lipophilic congeners; the major congeners 
(e.g., BDEs 47, 99, 100, 153) are mostly 
found in the pentaBDE commercial mixture 
used in polyurethane foams, and they have 
long half-lives (2–7 years) in humans (Geyer 
et al. 2004). Concerns have been raised about 
potential toxicity of PBDEs, focused mainly 
on thyroid-disrupting effects and develop-
mental neurotoxicity (Costa et al. 2008). In 
particular, hyperactivity, decreased habitu-
ation, and deficits in learning and memory 
have been reported in experimental animal 
studies (Costa and Giordano 2007).
Serum PBDE concentrations have been 
associated with reduced IQ and increased 
scores of attention problems, hyperactivity, 
and attention deficit/hyperactivity disorder 
(ADHD) index in children. A prenatal cohort 
established following the 11 September 
2001 World Trade Center (WTC) attack in 
New York City reported a decrease in Full-
Scale IQ (FSIQ) associated with increased 
levels of BDEs 47, 99, 100, or 153 conge-
ners in cord serum (Herbstman et al. 2010). 
A 10-fold increase in cord serum BDE-47 
was associated with a 5.5-point decrease 
(95% CI: –10.8, –0.2) in FSIQ at 4 years 
of age (Herbstman et al. 2010). In a recent 
study involving children of migrant farm 
workers, prenatal exposure to PBDEs was 
associated with lower FSIQ up to 7 years 
of age and higher ADHD index (Eskenazi 
et al. 2013). Collectively, these studies sug-
gest that prenatal PBDE exposures are associ-
ated with deficits in intellectual abilities and 
increased behavior problems in children. We 
hypothesized that prenatal PBDE exposure 
would be associated with decrements in cog-
nitive abilities and increases in hyperactivity 
behaviors in 5-year-old children enrolled in a 
U.S. birth cohort.
Methods
Study participants. Pregnant women were 
enrolled in the Health Outcomes and 
Measures of the Environment (HOME) 
Study between March 2003 and February 
2006 in Cincinnati, Ohio. The study was 
designed to investigate neurobehavioral and 
health effects of exposures to low-level, envi-
ronmental toxicants or suspected toxicants. 
Eligibility criteria for HOME study mothers 
were a) being pregnant at 16 (± 3) weeks of 
gestation; b) being ≥ 18 years old; c) resid-
ing in a house built before 1978 (which may 
contain leaded paint, a focus of another part 
of the overall study); d) having no history of 
human immunodeficiency virus (HIV) infec-
tion; and e) not taking medication for seizures 
or thyroid disorders. A total of 389 pregnant 
women participated and delivered live single-
ton infants. The children were followed up at 
1, 2, 3, 4, and 5 years of age for assessment 
of neurodevelopment, physical growth, and 
health conditions. We retained 309 mothers 
and their children in this analysis after 
excluding infants with major birth defects 
(n = 2), mothers with insufficient serum for 
PBDE measurement (n = 30), and those 
who did not complete any neurobehavioral 
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Background: Polybrominated diphenyl ethers (PBDEs) are persistent chemicals that have been 
widely used as flame retardants in furniture, carpet padding, car seats, and other consumer products 
during the past three decades.
oBjective: We examined whether in utero exposure to PBDEs is associated with child  cognitive 
function and behavior in a U.S. study sample.
Methods: In a prospective birth cohort, we measured maternal serum concentrations of BDE‑47 
and other PBDE congeners in 309 women at 16 weeks of gestation during 2003–2006 and fol‑
lowed their children in Cincinnati, Ohio. We measured cognitive and motor abilities using the 
Bayley Scales of Infant Development‑II at ages 1, 2, and 3 years; intelligence using the Wechsler 
Preschool and Primary Scale of Intelligence‑III at age 5 years; and children’s behaviors using the 
Behavioral Assessment System for Children‑2 annually at ages 2–5 years. We used linear mixed 
models or generalized estimating equations with adjustment for potential confounders to estimate 
associations between these outcomes and log10‑transformed PBDE concentrations.
results: The geometric mean of BDE‑47 in maternal serum (20.1 ng/g lipid) was comparable 
with U.S. adult national reference values. Prenatal BDE‑47 was not significantly associated with 
Bayley Mental or Psychomotor Development Indices at 1–3 years, but a 10‑fold increase in prena‑
tal BDE‑47 was associated with a 4.5‑point decrease (95% CI: –8.8, –0.1) in Full‑Scale IQ and a 
3.3‑point increase (95% CI: 0.3, 6.3) in the hyperactivity score at age 5 years.
conclusions: Prenatal exposure to PBDEs was associated with lower IQ and higher hyperactivity 
scores in children.
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assessments between 1 and 5 years of age 
(n = 48). The HOME study was approved 
by the institutional review boards at the 
Cincinnati Children’s Hospital Medical 
Center (CCHMC) and the CDC. The study 
mothers gave informed consent before enroll-
ment in the study and at postnatal follow-up 
visits for their children’s participation.
Maternal serum PBDE measurement. We 
measured serum PBDE concentrations dur-
ing early pregnancy. The women provided 
blood samples at the prenatal enrollment visit 
around 16 weeks of gestation. The serum 
samples were stored at –80°C and shipped to 
the CDC for testing of environmental con-
taminants. The PBDE congeners (BDEs 17, 
28, 47, 66, 85, 99, 100, 153, 154, 183) were 
measured at the CDC’s Persistent Organic 
Pollutants Biomonitoring Laboratory at the 
National Center for Environmental Health 
(NCEH), using gas chromatography/isotope 
dilution high-resolution mass spectrometry 
(Jones et al. 2012). The serum samples were 
pretreated and extracted by solid phase extrac-
tion. Blank samples were included in a set of 
test samples and quality control samples. The 
serum PBDE concentrations were calculated 
on a lipid basis (nanograms per gram lipid, 
including total cholesterol and triglycerides) 
to account for their lipophilic property. All 
309 subjects (100%) had detectable BDE-47. 
However, 30 subjects did not have enough 
serum for reliable quantification of other 
PBDE congeners, leaving 279 subjects tested 
for BDEs 99, 100, and 153. Among the 279 
subjects, 6 had concentrations of BDEs 99, 
100, or 153 below the limit of detection 
(LOD) (SjÖdin et al. 2008), and their values 
were replaced with the LOD divided by the 
square root of 2 (Hornung and Reed 1990). 
To maximize power and representativeness of 
total PBDE exposure, we focused on serum 
BDE-47, which accounted for 51% of all 
serum PBDE congeners and was available 
for all 309 subjects. In secondary analyses, we 
examined the association of the sum of four 
PBDE congeners (sum4: BDEs 47, 99, 100, 
153, accounting for 90% of the sum of all 
10 congeners tested) in 279 subjects.
Developmental and behavioral assess-
ments. We administered the Bayley Scales 
of Infant Development-II (BSID-II) (Bayley 
1993) to evaluate cognitive and motor devel-
opment during follow-up visits of the chil-
dren at 1, 2, and 3 years of age. The BSID-II 
yields Mental Development Index (MDI) 
and Psychomotor Development Index (PDI) 
standard scores. When the children were 
5 years of age, we administered the Wechsler 
Preschool and Primary Scale of Intelligence-III 
(WPPSI-III) to obtain FSIQ (Wechsler 2004). 
The MDI and FSIQ both measure cogni-
tive function and have a population mean of 
100 and a standard deviation of 15. When 
children were 2, 3, 4, and 5 years, their par-
ents completed the Behavioral Assessment 
System for Children-2 (BASC-2), which offers 
a comprehensive assessment of a child’s adap-
tive and problem behaviors in community 
and home settings (Reynolds and Kamphaus 
2004). It provides four composite scores 
for Externalizing Problems, Internalizing 
Problems, Behavioral Symptoms Index, and 
Adaptive Skills, as well as 12 clinical subscales 
and 5 content scales. Externalizing Problems 
include subscales of aggression and hyperactiv-
ity; Internalizing Problems include subscales 
of anxiety, depression, and somatization; 
Behavioral Symptoms Index includes subscales 
of aggression, hyperactivity, depression, atypi-
cality, withdrawal, and attention problems; 
Adaptive Skills include subscales of activity 
of daily living, adaptability, social skills, and 
functional communication. The hyperactiv-
ity subscale is included in both Externalizing 
Problems and Behavioral Symptoms Index 
composite scores. The BASC-2 scores have a 
mean of 50 and a standard deviation of 10. 
Except for Adaptive Skills and the correspond-
ing subscales, higher BASC-2 scores suggest 
nonoptimal behavior. 
All clinical assessments were performed 
by HOME Study staff trained and certified 
by a developmental psychologist (K.Y.). The 
assessors conducted the neurobehavioral 
assessments without knowledge of maternal 
PBDE levels.
Statistical analyses. We focused our sta-
tistical analyses on the associations between 
prenatal PBDE exposures and intellectual 
abilities and externalizing behavior problems 
and hyperactivity because of animal study 
evidence of hyperactivity and deficits in learn-
ing and memory (Costa and Giordano 2007). 
In secondary analyses, we also examined 
Bayley PDI, BASC-2 Internalizing Problems, 
Behavioral Symptoms Index, Adaptive Skills, 
and BASC-2 subscales for attention problems, 
aggression, anxiety, and withdrawal. The 
PBDE concentrations were log10 transformed 
because of the right-skewed distribution. We 
first estimated adjusted associations between 
log10 transformed maternal BDE-47 and 
FSIQ and externalizing behaviors at 5 years of 
age using generalized additive models (GAM) 
to examine whether the dose–response pat-
terns were approximately linear. We used 
linear mixed models to estimate regression 
estimates of PBDEs to take advantage of the 
longitudinal design and repeated measure-
ments of cognition and behavior in children. 
We examined associations between mater-
nal PBDEs and neurobehavioral outcomes at 
different ages by entering interaction terms 
between PBDEs (continuous variable) and 
child age (categorical variable) in the mixed 
models. We constructed a linear mixed model 
for MDI at 1, 2, and 3 years and FSIQ at 
5 years because MDI and FSIQ are statis-
tically equivalent, and MDI at 3 years and 
FSIQ at 5 years were highly correlated in 
this study, with Pearson correlation coeffi-
cient = 0.72. We constructed a linear mixed 
model for Externalizing Problems at 2, 3, 4, 
and 5 years. We also constructed another lin-
ear mixed model for hyperactivity subscale 
at 2, 3, 4, and 5 years. In secondary analy-
ses, we established a linear mixed model 
for PDIs at 1, 2, and 3 years. Additionally, 
we used separate linear mixed models for 
Internalizing Problems, Behavior Symptoms 
Index, Adaptive Skills, and BASC-2 subscales 
for attention problems, aggression, anxiety, 
and withdrawal at 2, 3, 4, and 5 years. We 
used an unstructured covariance structure in 
the linear mixed models based on the Akaike 
information criterion after comparing with an 
autoregressive covariance structure.
For all multiple regression models, 
we included a priori the following poten-
tial covariates: maternal age at enrollment, 
maternal race/ethnicity, education, marital 
status, maternal serum cotinine concentra-
tions at enrollment, maternal IQ [assessed by 
Wechsler Abbreviated Scale of Intelligence 
(WASI) (Wechsler 1999)], and child sex 
(Eskenazi et al. 2013; Herbstman et al. 2010). 
We also included maternal depression [Beck 
Depression Inventory II score at enrollment 
(Beck et al. 1996)], household income, and 
Home Observation for Measurement of the 
Environment (HOME) Inventory (Caldwell 
and Bradley 1984) measured at a 1-year home 
visit as covariates for adjustment in the multi-
ple regression models because of their correla-
tions with both prenatal PBDE concentrations 
and FSIQ at 5 years of age (p < 0.05). The 
potential covariates were coded as categorized 
or continuous variables as shown in Tables 1 
and 2. Finally, we examined maternal blood 
lead concentration (mean, 0.7 μg/dL) as a 
potential confounder, but it did not correlate 
with PBDEs (r = 0.09, p > 0.05), nor did it 
modify the regression coefficients of PBDEs 
on MDI/FSIQ, Externalizing Problems, and 
hyperactivity subscale by > 10%, and thus was 
not included in the final models.
We also examined binary measures for a 
child to be considered “at risk” of clinically 
significant developmental deficits (MDI/
WPPSI FSIQ < 85, PDI < 85) or behavioral 
problems (Externalizing Problems score ≥ 60, 
Internalizing Problems score ≥ 60, Behavioral 
Symptoms Index ≥ 60, Adaptive Skills 
score < 40, hyperactivity subscale score ≥ 60). 
We used adjusted generalized linear models 
(GLM) with generalized estimating equations 
(GEE) to estimate associations with repeated 
measurements from 1 through 5 years.
Sensitivity analyses. We tested the inter-
action of BDE-47 and child sex on neuro-
behavioral outcomes by including an 
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interaction term of BDE-47 (continuous 
variable) and sex (dichotomous variable) in 
the regression models with repeated measure-
ments. We repeated the analyses after exclud-
ing 16 mothers with BDE-47 > 100 ng/g lipid 
to evaluate the potential influence of PBDE 
concentrations higher than the 95th per-
centile on regression estimates. We assessed 
the potential impact of sample selection by 
examining the difference in demographics and 
socio economic status between the analytical 
sample of 309 subjects and the 80 subjects 
not included due to missing exposure or out-
come assessments. We further examined the 
difference in demographics, socioeconomic 
status, maternal PBDE concentrations, and 
Bayley scores between subjects with and with-
out follow-up at 5 years of age among the ana-
lytical sample of 309 subjects. The statistical 
computing was completed with SAS version 
9.3 (SAS Institute Inc., Cary, NC, USA), and 
the graphing was produced in R version 2.15 
(R Developmental Team; www.r-project.org/). 
The statistical tests were two-sided with a sig-
nificance level at a p-value of 0.05. For tests for 
statistical interactions, the significance level was 
set at a p-value of 0.10.
Results
The maternal serum PBDE concentrations 
and child neurodevelopmental test scores at 
5 years of age are shown by maternal and child 
characteristics (Table 1). The mean (± SD) 
age of 309 pregnant women at enrollment 
was 29.9 ± 5.6 years, 67% were non-Hispanic 
white, and 54% had a Bachelor’s degree or 
graduate education. The 309 women with 
BDE-47 data included in the analysis were 
more likely to be non-Hispanic white, older, 
and have higher education and household 
income than the 80 women from the origi-
nal HOME study cohort who were excluded 
due to missing exposure or neurobehavioral 
assessment (data not shown). However, the 
190 child participants who had an IQ test at 
age 5 years were not statistically different in 
demographics, socio economic status, maternal 
PBDE concentrations, and Bayley scores at 
ages 1–3 years from the 119 participants who 
did not complete IQ test at age 5 years (see 
Supplemental Material, Table S1).
The geometric mean (GM) of BDE-47 
in maternal serum was 20.1 ng/g lipid 
(median, 18.9 ng/g lipid; 10th–90th per-
centile, 6.4–67.9 ng/g lipid), and the 
GM of sum4BDEs was 37.7 ng/g lipid 
(median, 34.6 ng/g lipid; 10th–90th percen-
tile, 12.0–129.2 ng/g lipid). The Pearson cor-
relation coefficient between log10-transformed 
BDE-47 and sum4BDEs was 0.94 (p < 0.05).
Mothers who were non-Hispanic black 
and other race/ethnicity, or unmarried and 
not living with a partner had significantly 
higher serum BDE-47 concentrations, and 
their children had lower FSIQ at age 5 years 
(Table 1). Mothers < 25 years of age had the 
highest BDE-47 concentrations, and their 
children had the lowest FSIQ in the three age 
groups (Table 1). Mothers with household 
Table 1. Maternal serum PBDE concentrations around 16 weeks of gestation and child neurodevelopmental test scores at age 5 years by maternal and child 
characteristics.
Categorical characteristics
n at enrollment 
(%)
Maternal BDE‑47 
 (ng/g lipid) [GM (GSD)]
n with WPPSI  
at age 5 (%)
WPPSI FSIQ  
at age 5 (mean ± SD)
n with BASC‑2  
at age 5 (%)
BASC externalizing problems 
at age 5 (mean ± SD)
All participants 309 (100) 20.1 (2.61) 190 (100) 102.33 ± 15.20 194 (100) 47.13 ± 9.26
Maternal age (years)*,**
< 25 63 (20) 27.54 (2.24) 39 (21) 92.18 ± 13.60 39 (20) 48.71 ± 13.11
25–34 194 (63) 19.50 (2.69) 122 (64) 103.59 ± 14.47 128 (66) 46.78 ± 7.86
≥ 35 52 (17) 15.14 (2.57) 29 (15) 110.69 ± 13.49 27 (14) 46.44 ± 8.89
Maternal race/ethnicity*,**
Non‑Hispanic white 207 (67) 16.98 (2.51) 122 (64) 107.09 ± 13.55 124 (64) 47.48 ± 8.34
Non‑Hispanic black and others 102 (33) 28.84 (2.51) 68 (36) 93.79 ± 14.34 70 (36) 46.51 ± 10.74
Maternal education*,**
High school or less 70 (23) 28.84 (2.29) 44 (23) 90.23 ± 13.65 45 (23) 47.91 ± 11.35
Some college or 2‑year degree 72 (23) 22.91 (2.34) 50 (26) 98.58 ± 13.40 50 (26) 49.52 ± 10.69
Bachelor’s 101 (33) 16.98 (2.69) 60 (32) 110.48 ± 12.14 61 (31) 45.25 ± 6.22
Graduate or professional 66 (21) 15.14 (2.82) 36 (19) 108.75 ± 12.63 38 (20) 46.08 ± 8.06
Maternal marital status*,**
Married or living with partner 251 (81) 18.20 (2.63) 149 (78) 105.52 ± 14.26 153 (79) 46.52 ± 8.09
Not married and living alone 58 (19) 31.63 (2.19) 41 (22) 90.73 ± 12.81 41 (21) 49.39 ± 12.60
Household income*,**,#
< $20,000 63 (20) 32.36 (2.29) 44 (23) 88.45 ± 13.34 45 (23) 51.02 ± 12.56
$20,000–79,999 157 (51) 19.95 (2.63) 96 (51) 103.63 ± 13.63 97 (50) 45.63 ± 8.03
≥ $80,000 89 (29) 14.45 (2.40) 50 (26) 112.06 ± 10.13 52 (27) 46.56 ± 7.01
Child sex*
Male 141 (46) 17.78 (2.51) 83 (44) 100.40 ± 15.35 87 (45) 47.38 ± 8.24
Female 168 (54) 22.39 (2.63) 107 (56) 103.83 ± 15.00 107 (55) 46.93 ± 10.05
GM, geometric mean; GSD, geometric standard deviation. 
*p < 0.05 for BDE‑47. **p < 0.05 for FSIQ. #p < 0.05 for BASC Externalizing Problems. The statistical tests included t‑test, analysis of variance, or Student–Newman–Keuls test.
Table 2. Pearson correlation coefficients of continuous characteristics with maternal serum PBDE concentrations around 16 weeks of gestation, and child 
neuro developmental test scores at age 5 years.
Continuous characteristics
n at 
enrollment Mean ± SD
Pearson r with 
maternal BDE‑47 
(log10 ng/g lipid)
n with  
WPPSI  
at age 5 Mean ± SD
Pearson r with 




at age 5 Mean ± SD
Pearson r with BASC 
externalizing problems 
at age 5
Maternal IQ 301 107.16 ± 14.6 –0.24* 186 105.97 ± 15.4 0.50** 190 106.13 ± 15.5 –0.05
Maternal BDI depression 
score at baseline
307 9.60 ± 6.82 0.23* 189 9.75 ± 6.80 –0.26** 193 9.70 ± 6.75 0.29#
Maternal cotinine at baseline 
[GM (GSD)] (ng/mL)
309 0.04 (18) 0.29* 190 0.04 (14) –0.34** 194 0.04 (14) 0.10
HOME score at age 1 visit 297 39.36 ± 5.26 –0.27* 183 39.11 ± 5.55 0.45** 187 39.13 ± 5.61 –0.02
BDI, Beck Depression Index; GM, geometric mean; GSD; geometric standard deviation. 
*p < 0.05 for BDE‑47. **p < 0.05 for FSIQ. #p < 0.05 for BASC Externalizing Problems.
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income < $20,000 had the highest BDE-47 
concentrations, and their children had the 
lowest FSIQ and the highest Externalizing 
Problems score in the three income groups 
(Table 1). Mothers with high school or less 
education had higher BDE-47 concentrations 
than mothers with Bachelor’s or higher degree, 
and their children had the lowest FSIQ in the 
four education groups (Table 1). Maternal IQ 
and HOME Inventory scores were inversely 
correlated with serum BDE-47 concentration 
and positively correlated with child FSIQ, 
whereas high maternal depression score and 
higher serum cotinine levels were correlated 
with higher BDE-47 concentration and lower 
FSIQ (Table 2). Externalizing Problems scores 
were higher in children of mothers who had 
a higher depression  symptom score (Table 2).
There was an inverse association of mater-
nal BDE-47 concentrations with child FSIQ 
(Figure 1A). In repeated measurement analy-
ses, a 10-fold increase in maternal BDE-47 
exposure was associated with a significantly 
lower FSIQ score at age 5 years (–4.5 points; 
95% CI: –8.8, –0.1) (Figure 2). A 10-fold 
increase in maternal BDE-47 was associated 
with lower average MDI scores at 1, 2, and 
3 years of age, but differences were small and 
not statistically significant.
Maternal BDE-47 concentrations were 
associated with higher Externalizing Problems 
scores at age 5 years (Figure 1B). In repeated 
measurement analysis, maternal BDE-47 
concentrations were positively associated 
with Externalizing Problems score at ages 2 
and 3 years with statistical significance [e.g., 
3.1 points higher at 3 years of age (95% CI: 
0.3, 5.8) in association with a log10 increase in 
BDE-47] (Figure 2). At ages 4 and 5 years, the 
associations were positive but not statistically 
significant [e.g., 2.6 points higher (95% CI: 
–0.4, 5.5) at 5 years of age] (Figure 2). 
Hyperactivity subscale scores in early child-
hood also were positively and significantly 
associated with maternal BDE-47 concen-
trations [e.g., 3.3 points higher (95% CI: 
0.3, 6.3) at age 5 years] (Figure 2). Maternal 
BDE-47 concentration was not significantly 
associated with the Bayley PDI, BASC-2 
composite scores for Adaptive Skills or 
Internalizing Problems (which includes anxi-
ety, depression, and somatization subscales), 
or BASC-2 subscales for attention problems, 
aggression, anxiety, withdrawal behaviors (see 
Supplemental Material, Table S2). However, 
maternal BDE-47 was positively associated 
with Behavioral Symptoms Index (which 
includes subscales for hyperactivity, aggression, 
attention problems, and withdrawal, as well as 
depression and atypicality subscales) (Figure 2). 
Associations of sum4BDEs and MDI/
FSIQ and BASC-2 outcomes (Externalizing 
Problems, Behavioral Symptoms Index, and 
hyperactivity subscale scores) were very similar 
to corresponding associations with BDE-47 
(see Supplemental Material, Table S3).
MDI/FSIQ < 85 was not s ignif i-
cantly associated with maternal PBDE 
Figure 1. Scatter plots of maternal serum BDE‑47 concentrations and child cognitive and behavior rating scores at age 5 years with generalized additive model 
curve fitting: (A) WPPSI FSIQ; (B) BASC‑2 Externalizing Problems. Data points represent paired data from each mother–child dyad. Solid lines indicate the natural 
cubic spline of the covariates adjusted association, and dotted lines represent 95% CIs. The density of BDE‑47 distribution is shown as vertical bars on the log10‑
transformed x‑axis. Covariates adjusted include maternal age at enrollment, race, education, marital status, maternal serum cotinine concentrations at enroll‑
ment, maternal IQ, child sex, maternal depression, household income, and HOME Inventory score.
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Figure 2. Estimated score differences and 95% CIs in cognitive and behavior rating scores at ages 
1–5 years by a 10‑fold increase in prenatal PBDE concentrations: Bayley MDI/WPPSI FSIQ, BASC‑2 
Externalizing Problems score, BASC‑2 hyperactivity subscale score, and BASC‑2 Behavioral Symptoms 
Index. The numbers of children in the covariate adjusted mixed model for Bayley MDI/WPPSI FSIQ were 
285 at 1 year, 239 at 2 years, 220 at 3 years, and 179 at 5 years of age. The numbers of children in the mixed 
model for BASC‑2 outcomes were 240 at 2 years, 227 at 3 years, 165 at 4 years, and 183 at 5 years of age. 
Covariates adjusted include maternal age at enrollment, race, education, marital status, maternal serum 
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concentrations (Table 3). However, mater-
nal exposure to BDE-47 was associated with 
higher odds of being in the “at risk” range 
for Externalizing Problems, hyperactiv-
ity subscale score, and Behavioral Symptom 
Index (Table 3). For outcomes at 5 years of 
age, the odds ratios (ORs) and 95% CIs for 
a log10 increase in maternal BDE-47 were 
2.66 (95% CI: 0.47, 15.06) for Externalizing 
Problems score ≥ 60 (n = 17), 4.45 (95% CI: 
1.31, 15.14) for hyperactivity subscale 
score ≥ 60 (n = 19), and 4.80 (95% CI: 
1.19, 19.26) for Behavioral Symptoms Index 
≥ 60 (n = 16). The association between 
BDE-47 and Adaptive Skills score < 40 was 
not statistically significant in any of the ages 
from 2 through 5 years. At 5 years of age, the 
OR and 95% CI for a log10 increase in mater-
nal BDE-47 were 0.80 (95% CI: 0.29, 2.14) 
for Adaptive Skills score < 40 (n = 12). The 
association between maternal BDE-47 and 
Internalizing Problems score ≥ 60 was not 
statistically significant in any of the ages from 
2 through 5 years. At 5 years of age, the OR 
and 95% CI for a log10 increase in maternal 
BDE-47 were 2.37 (95% CI: 0.84, 6.63) for 
Internalizing Problems score ≥ 60 (n = 10). 
The results of sum4BDEs and at risk for 
clinically significant developmental deficits 
(MDI/FSIQ < 85, Externalizing Problems 
score ≥ 60, hyperactivity subscale score ≥ 60, 
Behavioral Symptoms Index ≥ 60) were simi-
lar to corresponding results of BDE-47 (see 
Supplemental Material, Table S4).
We identified no significant statistical 
interactions between BDE-47 and child sex 
in the linear mixed models of MDI/FSIQ 
[p of the interaction term (pinteraction) = 0.78], 
Externalizing Problem score (pinteraction = 0.17), 
and hyperactivity subscale score (pinteraction 
= 0.39). Excluding 16 mothers with BDE-47 
> 100 ng/g lipid yielded results on MDI/FSIQ, 
Externalizing Problems, hyperactivity subscale, 
and Behavioral Symptoms Index similar to the 
full sample of 309 women (data not shown). 
Associations between maternal BDE-47 con-
centrations and measures of cognitive abilities 
estimated using one linear regression model 
for WPPSI FSIQ at age 5 years and a sepa-
rate mixed model for Bayley MDI scores at 
1, 2, and 3 years of age were very similar to 
corresponding estimates based on a single 
mixed model for the MDI scores and age 5 
WPPSI FSIQ (see Supplemental Material, 
Table S5). We also tested wet-based BDE-47 
and sum4BDEs as independent variables with 
adjustment for total lipids as a covariate in lin-
ear mixed models, and the results were similar 
to lipid-based analyses (data not shown).
Discussion
We found evidence that prenatal exposure to 
brominated flame retardants, assessed from 
PBDE maternal serum concentrations mea-
sured at approximately 16 weeks of gestation, 
was associated with lower FSIQ and higher 
scores for hyperactive behaviors in 5-year-old 
children enrolled in a prospective U.S. birth 
cohort that had serum PBDE concentrations 
comparable to the U.S. average (SjÖdin et al. 
2008). These results confirm previous study 
findings that suggest that PBDEs may be 
developmental neurotoxicants.
The results of our study were remarkably 
consistent with those of two previous stud-
ies that found brominated flame retardants 
were associated with decrements in FSIQ and 
increases in hyperactive behaviors or ADHD 
index. The estimated decrement in FSIQ at 
age 5 years (–4.5; 95% CI: –8.8, –0.1) asso-
ciated with a 10-fold increase in BDE-47 
exposure in this study is consistent with other 
reports (WTC cohort: –5.5 points; 95% CI: 
–10.8, –0.2) at age 4 years related to a 10-fold 
increase in cord BDE-47 (derived from 
original estimate of natural log BDE-47); 
California farming community cohort: –4.7 
points (95% CI: –9.4, 0.1) at age 7 years 
related to a 10-fold increase in maternal 
sum4BDEs) (Eskenazi et al. 2013; Herbstman 
et al. 2010). Women in the HOME study 
cohort had higher median prenatal BDE-47 
exposure (18.9 ng/g lipid) than did the WTC 
cohort (11.2 ng/g lipid) (Herbstman et al. 
2010) and the California farming commu-
nity cohort (15.7 ng/g lipid) (Eskenazi et al. 
2013). Another study in the Netherlands with 
much lower median prenatal BDE-47 lev-
els (0.9 ng/g lipid) and smaller sample size 
(n = 62) did not report a correlation with 
WPPSI IQ at 5–6 years of age (Roze et al. 
2009). We did not find an association of pre-
natal PBDE exposure and Bayley MDI and 
PDI scores in the first 3 years. Two studies, 
using breast milk PBDE levels, found no 
associations between BDE-47 and Bayley 
scores in infants and toddlers (Chao et al. 
2011; Gascon et al. 2012). BDE-209 was 
not measured in most U.S. studies, includ-
ing ours. Although we identified an inverse 
association between maternal PBDE exposure 
and child FSIQ at age 5 years, we did not find 
a significant association with FSIQ < 85.
We found that maternal PBDE expo-
sure was related to higher risk of children 
having externalizing behavior problems or 
hyperactivity in the “at risk” range of clini-
cal significance. This is consistent with the 
study from the California farming commu-
nity, which found a 2–3 times higher risk of 
ADHD index in the “moderately or mark-
edly atypical” range (Eskenazi et al. 2013). 
Two smaller studies in Europe had reported 
significant deficits in attention from pre-
natal or postnatal exposures (Gascon et al. 
2011; Roze et al. 2009). Another study from 
North Carolina used breast milk PBDE lev-
els (median, 28.7 ng/g lipid) and reported 
higher externalizing behavior domain scores 
and activity/impulsivity behaviors related 
to PBDE exposure (Hoffman et al. 2012). 
These results suggest that PBDEs, like lead 
and other environmental toxicants, may be a 
risk factor for the development of hyperactiv-
ity and ADHD in children (Froehlich et al. 
2009; Lanphear 2012).
The potential mechanisms of PBDEs on 
cognitive function and hyperactivity have 
been postulated to include induced neuro-
nal apoptosis, decreased neuronal migra-
tion, interrupted intracellular calcium (Ca2+) 
homeostasis, and altered neurotransmitter 
release and function (Dingemans et al. 2011). 
PBDEs and their hydroxylated metabolites 
(OH-PBDEs) can bind to the serum-binding 
proteins transthyretin and thyroxine-binding 
globulin, affect deiodinase enzyme activity, 
and alter thyroid hormone metabolism and 
excretion, resulting in reduced thyroxine lev-
els in experimental animals (Butt et al. 2011; 
Marchesini et al. 2008; Meerts et al. 2000; 
Szabo et al. 2009; Zhou et al. 2002). Human 
studies also observed PBDE-associated thy-
roid hormones (thyroid-stimulating hormone, 
total and free thyroxine, total and free triio-
dothyronine) disruption during pregnancy 
Table 3. Estimated ORs (95% CIs) of having cognitive and behavior rating scores 1 SD from the population mean at ages 1–5 years by a 10‑fold increase in mater‑
nal BDE‑47 concentrations.
Age (years)
MDI/FSIQ < 85 Externalizing Problems ≥ 60 Hyperactivity subscale ≥ 60 Behavioral Symptoms Index ≥ 60
n (%) OR (95% CI) n (%) OR (95% CI) n (%) OR (95% CI) n (%) OR (95% CI) 
1 52 (18.25) 1.22 (0.51, 2.91) — — — — — —
2 78 (32.64) 0.83 (0.39, 1.78) 12 (5.00) 5.86 (2.21, 15.55) 28 (11.67) 3.06 (1.17, 7.98) 14 (5.83) 1.30 (0.44, 3.84)
3 51 (23.18) 1.76 (0.78, 3.99) 37 (16.30) 2.13 (0.99, 4.56) 33 (14.54) 2.68 (1.17, 6.16) 32 (14.10) 2.54 (1.08, 5.98)
4 — — 17 (10.30) 1.51 (0.44, 5.21) 17 (10.30) 2.22 (0.55, 9.01) 13 (7.88) 2.02 (0.49, 8.39)
5 25 (13.97) 1.70 (0.36, 7.94) 17 (9.29) 2.66 (0.47, 15.06) 19 (10.38) 4.45 (1.31, 15.14) 16 (8.74) 4.80 (1.19, 19.26)
Adjusted for maternal age at enrollment, race, education, marital status, maternal serum cotinine concentrations at enrollment, maternal IQ, child sex, maternal depression, household 
income, and HOME Inventory score.
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(Chevrier et al. 2010; Herbstman et al. 2008; 
Lin et al. 2011; Stapleton et al. 2011; Zota 
et al. 2011). Thyroid disruption may be a 
critical underlying mechanism related to the 
developmental neurotoxicity of PBDEs and 
their metabolites (Dingemans et al. 2011); 
however, the recent study in the California 
farming community found significant asso-
ciations with neurobehavioral deficits even 
after adjusting for maternal thyroid hormones 
(Eskenazi et al. 2013). This suggests that 
other mechanisms might also be important. 
In addition to thyroid receptors, PBDEs 
and OH-PBDEs have also been shown to 
bind with estrogen, androgen, progesterone, 
glucocorticoid, gamma aminobutyric acid A 
(GABAA), and nicotinic acetylcholine (nACh) 
receptors (Dingemans et al. 2011; Hamers 
et al. 2006; Hendriks et al. 2010).
In 2009, the United Nation Environment 
Programme (UNEP) added penta- and 
octaBDEs, two of the three existing com-
mercial PBDE formulations, to the list of 
banned persistent organic pollutants (POPs) 
because of concerns about bioaccumulation 
and toxicity in wildlife and mammals (UNEP 
2009). In 2004, penta- and octaBDEs were 
voluntarily withdrawn from the U.S. mar-
ket, but products manufactured before then 
may still contain PBDEs, which can con-
tinue to be released into the environment 
by regular use, volatilization, and deposition 
in indoor dust. PBDEs are persistent in the 
environment and they bioaccumulate in the 
food chain. Humans are exposed to PBDEs 
primarily through dust ingestion and food 
intake (Lorber 2008; Schecter et al. 2006). 
U.S. women of reproductive age had GM of 
BDE-47 at 21 ng/g lipid in the NHANES 
(National Health and Nutrition Examination 
Survey) 2003–2004, compared with only 
2–3 ng/g lipid in Europe and Asia, largely due 
to higher U.S. standards to prevent flammabil-
ity in furniture (Kim et al. 2012; Vizcaino 
et al. 2011). The results from this and other 
observational human studies support efforts to 
reduce pentaBDE exposures in the U.S. pop-
ulation, especially for pregnant women and 
young children. Unfortunately, brominated 
flame retardants are persistent and Americans 
are likely exposed to higher PBDE levels than 
people from other parts of the world; thus, it 
is likely that it will take decades for the PBDE 
levels in the U.S. population to be reduced to 
current European or Asian levels.
This study has notable strengths and limi-
tations. We successfully followed study partici-
pants from a general population with serum 
levels similar to U.S. adults, and examined 
cognitive and behavioral outcomes in a pro-
spective birth cohort with repeated follow-ups 
through age 5 years (follow-up rate 95% at 
1 year, 81% at 2 years, 76% at 3 years, 57% 
at 4 years, and 63% at 5 years of age in this 
study sample of 309 mother–child pairs). We 
were able to adjust for a variety of potential 
confounders, including maternal depression, 
maternal IQ, sociodemographic factors, and 
exposure to cotinine. Even so, the possibil-
ity of unmeasured confounding cannot be 
ruled out, especially behavioral and lifestyle 
factors which may affect both exposure to 
PBDEs and child neurodevelopment (Buttke 
et al. 2013). We did not have a measure for 
BDE-209 in maternal serum; BDE-209 is 
the major congener of decaBDE that is still 
widely used in the United States (Costa and 
Giordano 2011). We also did not have mea-
sures of PBDE levels in child serum, which 
may be higher than maternal levels (Eskenazi 
et al. 2013; Toms et al. 2009). Finally, we 
lacked a measure of OH-PBDEs, which may 
be more important than PBDEs because of 
their potency for receptor binding and struc-
tural similarity to thyroxine (Dingemans 
et al. 2011; Li et al. 2010; Wan et al. 2009). 
However, a recent report suggests a high cor-
relation between maternal total PBDEs and 
total OH-PBDEs (Pearson r = 0.76) (Chen 
et al. 2013).
In summary, the results of this study 
confirmed those of previous studies, which 
showed that prenatal exposure to PBDEs is 
significantly associated with reduced FSIQ 
in children. We found that prenatal exposure 
to PBDEs is also significantly associated with 
increases in scores of externalizing problems 
and hyperactive behaviors in children. The 
research highlights the need to reduce inad-
vertent exposure to PBDEs in the home and 
office environment (e.g., via dust), and in 
diet (e.g., via fish or meat products), to avert 
potential developmental neurotoxicity in 
pregnant women and young children (Lorber 
2008; Schecter et al. 2006). Additional 
research is needed to illustrate the mecha-
nistic pathways linking PBDE exposure and 
neurodevelopmental deficits and to investi-
gate BDE-209 and OH-PBDEs for human 
developmental toxicity. Finally, research on 
the neurodevelopmental toxicity of the other 
flame retardants used to replace PBDEs is also 
urgently needed.
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